Harnessing Monocytes for a Liposomal Rosiglitazone-Mediated Anti-Inflammatory Effect
<img src=" https://s3.amazonaws.com/production.scholastica/article/38312/large/prnano_842022.jpg?1663092842"> Rosiglitazone, an anti-diabetic drug used for treating type Ⅱ diabetes mellitus with known anti-inflammatory properties, was withdrawn from the European market. The United States Food and Dr...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Andover House Inc.
2022-09-01
|
| Цуврал: | Precision Nanomedicine |
| Онлайн хандалт: | https://doi.org/10.33218/001c.38312 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|